Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

Not yet recruiting

• Conditions: Metabolic Syndrome

• Registration Number: NCT06363864
• Lead Sponsor: Leeuwenhoek Laboratories Co. Ltd.

Brief Summary

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-04
• Study First Submitted: 2024-04-09
• Study First Submitted QC: 2024-04-09
• Last Update Submitted: 2024-04-09
• Study First Posted: 2024-04-12
• Last Update Posted: 2024-04-12
• Study Start: 2024-04-14
• Primary Completion: 2029-10-31
• Study Completion: 2029-10-31

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

• Capable adults weigh ≥ 50 kg

Exclusion Criteria

• Not Taiwanese
• Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
• Incapacity
• Limited disposing capacity
• Mental disorders or intellectual disabilities

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Concentration changes of small molecules in blood.	Up to six years	Concentrations of small molecules in healthy individuals and metabolic syndrom patients will be analyzed to identify specific biomarkers for metabolic syndrome.